ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011

NCI to set separate payline for R01s over $700,000.

February 13, 2004

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

Cancer Informatics: NCI Calls On Users To Help Redesign Physician’s Data Query

February 13, 1998

In Brief: Susumu Tonegawa To Receive Bristol-Myers Award; Mark Green Named Director Of UCSD Cancer Center

March 7, 1986

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996